GLP-1 Medications for Heart Failure
Heart failure means the heart cannot pump blood efficiently enough to meet the body needs, and excess weight significantly worsens outcomes. The STEP-HFpEF trial showed semaglutide improves heart failure symptoms, exercise capacity, and quality of life in addition to weight loss. Heart Failure affects approximately 6.7 million American adults, and GLP-1 medications offer a clinically proven treatment option.
Prevalence
approximately 6.7 million American adults
Recommended Medications
2
Treatment Type
GLP-1 Agonist
How GLP-1 Medications Help with Heart Failure
The STEP-HFpEF trial showed semaglutide improves heart failure symptoms, exercise capacity, and quality of life in addition to weight loss. For patients with heart failure, GLP-1 medications address the underlying metabolic dysfunction that makes weight management difficult. Clinical trials have consistently shown that GLP-1 treatment produces significant improvements in both weight and condition-specific outcomes.
Recommended GLP-1 Medications for Heart Failure
Based on clinical evidence, the following GLP-1 medications are recommended for patients with heart failure:
Semaglutide
Wegovy / Ozempic
Tirzepatide
Zepbound / Mounjaro
Detailed Medication Guides for Heart Failure
Heart Failure & GLP-1 FAQ
Can GLP-1 medications help with heart failure?
Yes. The STEP-HFpEF trial showed semaglutide improves heart failure symptoms, exercise capacity, and quality of life in addition to weight loss. Clinical evidence supports the use of GLP-1 medications like semaglutide and tirzepatide for patients with heart failure.
Which GLP-1 medication is best for heart failure?
Semaglutide is often the first-line recommendation for heart failure due to its strong clinical evidence. Your provider will evaluate your specific situation to determine the best option.
How much weight can I lose with GLP-1 if I have heart failure?
Weight loss results are generally comparable to clinical trial averages (15-22% of body weight), though individual results vary based on the severity of heart failure and other health factors.
How prevalent is heart failure?
Heart Failure affects approximately 6.7 million American adults. GLP-1 medications represent a significant treatment advancement for patients dealing with this condition alongside excess weight.